These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 2260623

  • 1. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
    Abdel-Aziz G, Lebeau G, Rescan PY, Clément B, Rissel M, Deugnier Y, Campion JP, Guillouzo A.
    Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Morphopathological changes before and after biliodigestive derivation in experimental cirrhosis induced by biliary ligation in the rat].
    Marinelli Ibarreta A, Sánchez Movilla A, Izquierdo F, Burgos Lázaro F, Arce Alvarez A, del Castillo-Olivares Ramos JL.
    Rev Esp Enferm Dig; 1995 Jan; 87(1):25-31. PubMed ID: 7727164
    [Abstract] [Full Text] [Related]

  • 6. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
    Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A.
    Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P, Criado M, Hidalgo F, Flores O, Arévalo MA, Eleno N, Sánchez-Rodríguez A, López-Novoa JM, Esteller A.
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
    Ruf G, Mappes HJ, Koch H, Baumgartner U, Hagmann W, Farthmann EH.
    Hepatogastroenterology; 1996 Mar; 43(7):121-6. PubMed ID: 8682446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of ischemia on the regeneration of the cholestatic liver. An experimental study.
    Karavias D, Tsamandas AC, Tepetes K, Kritikos N, Kourelis T, Mirra N, Bonikos DS, Androulakis J.
    Hepatogastroenterology; 2002 Mar; 49(44):456-60. PubMed ID: 11995473
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats.
    Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A, Watanabe A.
    Hepatology; 1995 Mar; 21(3):787-95. PubMed ID: 7875677
    [Abstract] [Full Text] [Related]

  • 18. The extracellular matrix in hepatic regeneration. Localization of collagen types I, III, IV, laminin, and fibronectin.
    Martinez-Hernandez A, Delgado FM, Amenta PS.
    Lab Invest; 1991 Feb; 64(2):157-66. PubMed ID: 1997730
    [Abstract] [Full Text] [Related]

  • 19. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC, Chung JJ.
    J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
    [Abstract] [Full Text] [Related]

  • 20. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
    Türkçapar N, Bayar S, Koyuncu A, Ceyhan K.
    Hepatogastroenterology; 2003 Dec; 50(51):680-3. PubMed ID: 12828059
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.